The predictive power of free (vs. total) testosterone in aggressive prostate cancer.

被引:0
|
作者
Towe, Maxwell M. [1 ]
Huynh, Linda My [1 ]
El Khatib, Farouk [1 ]
Osman, Mohamad M. [1 ]
Yafi, Faysal A. [1 ]
Ahlering, Thomas Edward [1 ]
机构
[1] Univ Calif Irvine, Orange, CA USA
关键词
D O I
10.1200/JCO.2019.37.15_suppl.e16570
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16570
引用
收藏
页数:2
相关论文
共 50 条
  • [21] The relationship between total and free serum testosterone and the risk of prostate cancer and tumour aggressiveness
    Morote, Juan
    Ramirez, Cristobal
    Gomez, Esther
    Planas, Jacques
    Raventos, Carles X.
    de Torres, Ines M.
    Catalan, Roberto
    BJU INTERNATIONAL, 2009, 104 (04) : 486 - 489
  • [22] Behavior of total and free serum testosterone as a predictor for the risk of prostate cancer and its aggressiveness
    Regis, L.
    Planas, J.
    Celma, A.
    de Torres, I. M.
    Ferrer, R.
    Morote, J.
    ACTAS UROLOGICAS ESPANOLAS, 2015, 39 (09): : 573 - 581
  • [23] Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer
    Loeb, Stacy
    Folkvaljon, Yasin
    Damber, Jan-Erik
    Alukal, Joseph
    Lambe, Mats
    Stattin, Paer
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (13) : 1430 - +
  • [24] The predictive value of the prostate health index vs. multiparametric magnetic resonance imaging for prostate cancer diagnosis in prostate biopsy
    Jiří Stejskal
    Vanda Adamcová
    Miroslav Záleský
    Vojtěch Novák
    Otakar Čapoun
    Vojtěch Fiala
    Olga Dolejšová
    Hana Sedláčková
    Štěpán Veselý
    Roman Zachoval
    World Journal of Urology, 2021, 39 : 1889 - 1895
  • [25] The predictive value of the prostate health index vs. multiparametric magnetic resonance imaging for prostate cancer diagnosis in prostate biopsy
    Stejskal, Jiri
    Adamcova, Vanda
    Zalesky, Miroslav
    Novak, Vojtech
    Capoun, Otakar
    Fiala, Vojtech
    Dolejsova, Olga
    Sedlackova, Hana
    Vesely, Stepan
    Zachoval, Roman
    WORLD JOURNAL OF UROLOGY, 2021, 39 (06) : 1889 - 1895
  • [26] Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia
    Watts, Eleanor L.
    Perez-Cornago, Aurora
    Fensom, Georgina K.
    Smith-Byrne, Karl
    Noor, Urwah
    Andrews, Colm D.
    Gunter, Marc J.
    Holmes, Michael, V
    Martin, Richard M.
    Tsilidis, Konstantinos K.
    Albanes, Demetrius
    Barricarte, Aurelio
    Bueno-de-Mesquita, Bas
    Chen, Chu
    Cohn, Barbara A.
    Dimou, Niki L.
    Ferrucci, Luigi
    Flicker, Leon
    Freedman, Neal D.
    Giles, Graham G.
    Giovannucci, Edward L.
    Goodman, Gary E.
    Haiman, Christopher A.
    Hankey, Graeme J.
    Huang, Jiaqi
    Huang, Wen-Yi
    Hurwitz, Lauren M.
    Kaaks, Rudolf
    Knekt, Paul
    Kubo, Tatsuhiko
    Langseth, Hilde
    Laughlin, Gail
    Le Marchand, Loic
    Luostarinen, Tapio
    MacInnis, Robert J.
    Maenpaa, Hanna O.
    Mannisto, Satu
    Metter, Jeffrey E.
    Mikami, Kazuya
    Mucci, Lorelei A.
    Olsen, Anja W.
    Ozasa, Kotaro
    Palli, Domenico
    Penney, Kathryn L.
    Platz, Elizabeth A.
    Rissanen, Harri
    Sawada, Norie
    Schenk, Jeannette M.
    Stattin, Par
    Tamakoshi, Akiko
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (07) : 1033 - 1046
  • [27] PREDICTIVE ABILITY OF FREE TESTOSTERONE ON SEXUAL FUNCTION IN PROSTATE CCNCER
    Choi, E.
    Towe, M.
    Huynh, L.
    El-Khatib, F.
    Yafi, F.
    Ahlering, T.
    JOURNAL OF SEXUAL MEDICINE, 2021, 18 (03): : S8 - S8
  • [28] Low serum testosterone levels are predictive of prostate cancer
    Mearini, Luigi
    Zucchi, Alessandro
    Nunzi, Elisabetta
    Villirillo, Tommaso
    Bini, Vittorio
    Porena, Massimo
    WORLD JOURNAL OF UROLOGY, 2013, 31 (02) : 247 - 252
  • [29] Low serum testosterone levels are predictive of prostate cancer
    Luigi Mearini
    Alessandro Zucchi
    Elisabetta Nunzi
    Tommaso Villirillo
    Vittorio Bini
    Massimo Porena
    World Journal of Urology, 2013, 31 : 247 - 252
  • [30] Identifying a novel glycolytic inhibitor for treatment of aggressive prostate cancer.
    Stoyanova, Tanya Ivanova
    Rice, Meghan A.
    Kumar, Vineet
    Tailor, Dhanir
    Garcia-Marques, Fernando Jose
    Bermudez, Abel
    Kanchustambham, Vijayalakshmi
    Shankar, Vishnu
    Inde, Zintis
    Pandrala, Mallesh
    Nolley, Rosalie
    Ghoochani, Ali
    Liu, Shiqin
    Aslan, Merve
    Agarwal, Arushi
    Buckup, Mark
    Hsu, En-Chi
    Going, Catherine C.
    Peehl, Donna M.
    Dixon, Scott J.
    Zare, Richard N.
    Brooks, James D.
    Pitteri, Sharon J.
    Malhotra, Sanjay V.
    Stoyanova, Tanya
    CANCER RESEARCH, 2021, 81 (13)